Education
About Us
Working with TipRanks
Follow Us
Acro Biomedical Co (ACBM)
:ACBM
ACBM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.11 - $0.11
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$42.03K
Enterprise ValueN/A
Total Cash (Recent Filing)$37.61K
Total Debt (Recent Filing)$3.27K
Price to Earnings (P/E)―
Beta-2.70
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding60,042,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)341.91
Price to Cash Flow (P/CF)N/A
P/FCF Ratio10125.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACBM FAQ
What was Acro Biomedical Co ’s price range in the past 12 months?
Acro Biomedical Co lowest stock price was $0.10 and its highest was $0.10 in the past 12 months.
What is Acro Biomedical Co ’s market cap?
Acro Biomedical Co ’s market cap is $42.03K.
When is Acro Biomedical Co ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acro Biomedical Co ’s earnings last quarter?
Acro Biomedical Co released its earnings results on Feb 15, 2018. The company reported $0.002 earnings per share for the quarter, beating the consensus estimate of N/A by $0.002.
Is Acro Biomedical Co overvalued?
According to Wall Street analysts Acro Biomedical Co ’s price is currently Overvalued.
Does Acro Biomedical Co pay dividends?
Acro Biomedical Co does not currently pay dividends.
What is Acro Biomedical Co ’s EPS estimate?
Acro Biomedical Co ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acro Biomedical Co have?
Acro Biomedical Co has 60,042,000 shares outstanding.
What happened to Acro Biomedical Co ’s price movement after its last earnings report?
Acro Biomedical Co reported an EPS of $0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Acro Biomedical Co ?
Currently, no hedge funds are holding shares in ACBM
---
Company Description
Acro Biomedical Co
Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. It intends to conduct research and development on its own proprietary products based on cordyceps sinensis. The company was founded on September 24, 2014 and is headquartered in Fishers, IN.
---
Technical Analysis
---